HOME › DRUGS › CABOTEGRAVIR
ACTIVE SUBSTANCE / INN

CABOTEGRAVIR

Brand name(s): Apretude, APRETUDE, Vocabria, CABENUVA KIT
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
NDA215499
NDA212888
ACTIVE SUBSTANCE
Cabotegravir
REGULATORS
FDA · EMA
SPONSORS / MAH
ViiV Healthcare B.V., VIIV HLTHCARE
TOTAL APPLICATIONS
4
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
APRETUDENDA215499VIIV HLTHCAREPrescription
CABENUVA KITNDA212888VIIV HLTHCAREPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
VocabriaViiV Healthcare B.V.Authorised17/12/2020HIV Infections
ApretudeViiV Healthcare B.V.Authorised15/09/2023HIV Infections

FULL INTELLIGENCE ON CABOTEGRAVIR

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →